Elicit: Efficacy of SGLT Activators on Water Absorption (public)
Efficacy of SGLT Activators on Water Absorption
How effective are sodium-glucose cotransport activators in improving water absorption?
Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.
Abstract
Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‑alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.
Methods
We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.
- Papers identified with Elicit search: n = 997
- Papers screened out: n = 968
- Papers included for extraction: n = 29
Screening
We screened in sources based on their abstracts that met these criteria:
- SGLT Activators/Enhancers: Does this study investigate sodium-glucose cotransporter (SGLT) activators or enhancers?
- Water Absorption Outcome: Does this study measure water absorption as a primary or secondary outcome?
- In Vivo Studies: Is this an in vivo study (human studies or animal studies)?
- Appropriate Study Design: Is this study one of the following designs: randomized controlled trial, controlled clinical trial, cohort study, case-control study, systematic review, or meta-analysis?
- SGLT Activators vs Inhibitors: Does this study focus on SGLT activators/enhancers rather than SGLT inhibitors?
- Beyond In Vitro Only: Does this study include in vivo components?
- Publication Quality: Is this study a peer-reviewed research article?
Data extraction
Results
Characteristics of Included Studies
| Study | Study Design | Clinical Condition | Intervention Type | Primary Outcome Measure | Full text retrieved |
|---|---|---|---|---|---|
| Wapnir et al., 1988 | Animal experimental | Osmotic diarrhea (rats) | L-alanine, protein hydrolysate in oral hydration solution | Water and sodium absorption | No |
| Rongione et al., 2001 | Animal experimental; in vivo physiological | Normal dogs | EGF, TGF | Sodium, chloride, water, glucose absorption | No |
| Grahammer et al., 2006 | Animal experimental; in vivo physiological | Normal and dexamethasone-treated mice | Dexamethasone | SGLT1/NHE3 activity, sodium absorption | No |
Summary of study characteristics
- Study design: 23 studies were animal experimental (including in vivo physiological models), 6 studies were human intervention studies.
- Clinical condition and species: 12 studies used diarrhea models, 7 studies used normal (healthy) animals or humans.
Water Absorption Outcomes
| Study | Activator Type | Water Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased water absorption | “Very significant increase” | No mention found |
| Elliott et al., 1986 | Glucose (oral rehydration solution) | Increased water absorption | +98.6±16 microliters/minute/gram | p<0.01 |
Sodium Absorption Outcomes
| Study | Activator Type | Sodium Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased sodium absorption | “Very significant increase” | No mention found |
| Elliott et al., 1986 | Glucose (oral rehydration solution) | No mention found | N/A | N/A |
Comparative Effectiveness of Different Activators
| Study | Activator(s) Compared | Relative Effectiveness | Notes |
|---|---|---|---|
| Wapnir et al., 1988; Wapnir et al., “Enhancement by Alanine” | L-alanine, protein hydrolysate, glycine | Alanine/protein hydrolysate > glycine | Alanine/protein hydrolysate most effective at higher sodium |
| Aguero et al., 1990 | Glutamine vs. control | Glutamine increased sodium absorption 300% | Both normal and diarrheic rats |
Context-Dependent Effects and Generalizability
- Limitations of the evidence: Many studies lacked detailed reporting of sample size, sex, or age.